Biomedical Research Advances for Space Health (BRASH 2101)
TRISH is seeking research proposals with emerging scientific and biomedical advances, disruptive technologies, and new therapies and engineering capabilities with the potential to protect health in deep space.
\With the BRASH 2101 solicitation, TRISH is seeking novel research and multi-disciplinary approaches to reduce health risks through manipulation of human metabolism and homeostasis at the cellular or whole organism level.
Modifying metabolic and homeostatic processes has the potential to reduce the necessary supplies and outputs of crewed missions in the highly resource-constrained environment of deep space. This strategy may also mitigate maladaptive processes the body undergoes in microgravity such as muscle and bone loss, or reduce tissue damage as a result of space radiation exposure. TRISH seeks to examine the feasibility of this method by awarding proof-of-concept grants to projects that assess the risks and potential benefits of these types of approaches.
The Step-1 proposals are due on Dec. 21, 2020 by 5 p.m. ET. Step-2 proposals from selected investigations will be due on March 30, 2021. Selections will be announced in August 2021.
TRISH held a pre-solicitation webinar on Friday, Nov. 13. View the recording.
Catalyst Proposals grants are unsolicited proposals that may be submitted at any time. This funding vehicle is best suited for pilot or proof-of-principle projects with a small amount of funding and a short duration.
Schedule: Unsolicited or directed. Submit any time.
Annual Funding Amount: Generally less than $100,000 but can be up to $350,000
Duration: Up to two years
Review: Programmatic relevance and external scientific peer reviews. Reviewed as received.
TRISH Cost Sharing Requirements
Areas of Interest